Active	Status	Sponsor type	Region	Phase	Filter
12 Active 3 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

12 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ramos, Manuel
ABIGAIL, NCT04603183 / 2020-001648-24: ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL	Active, not recruiting	2	162	Europe	Abemaciclib, Verzenios, Paclitaxel, Paclitaxel Teva, Letrozole, Fulvestrant	MedSIR, Eli Lilly and Company	Breast Cancer Metastatic	06/24	06/25
PHERGAIN-2, NCT04733118 / 2020-003205-66: Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer	Active, not recruiting	2	393	Europe	Trastuzumab and Pertuzumab (FDC SC) and T-DM1, Trastuzumab emtansine, Phesgo, Kadcyla	MedSIR, Hoffmann-La Roche	Early Breast Cancer	09/25	03/28
Garcia-Tejedor, Amparo
NCT06339658: ICG vs Blue Patent for TAD in cN1 Breast Carcinoma After Neoadjuvant Chemotherapy	Recruiting	N/A	43	Europe	Targeted axillary dissection (TAD) by ICG, Targeted axillary dissection (TAD) by Blue patent	Hospital Universitari de Bellvitge	Breast Cancer, Axillary Metastases	01/26	01/26
NCT03571776: Anti-mullerian Hormone (AMH) After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial	Terminated	N/A	158	Europe	Surgery, Sclerotherapy	Hospital Universitari de Bellvitge	Endometrioma, Fertility Disorders	01/23	01/23
NCT05040685: Axillary Reverse Mapping in Breast Cancer	Completed	N/A	43	Europe	Axillary mapping reverse	Hospital Universitari de Bellvitge	Lymph Node Cancer Metastatic	07/23	07/23
NCT05763641: TAD After Chemotherapy in Locally Advanced Breast Cancer	Recruiting	N/A	162	Europe	Target Axillary Dissection	Hospital Universitari de Bellvitge	Sentinel Lymph Node, Breast Cancer, Locally Advanced	04/25	04/25
NCT05782686: Impact of Systematic Shaving on Margins	Recruiting	N/A	234	Europe	Margin shaving	Hospital Universitari de Bellvitge	Margin, Tumor-Free, Breast Cancer, Surgery	06/24	10/25
NCT04389216: Radiofrequency Ablation (RFA) in Breast Tumors	Recruiting	N/A	30	Europe	Cool-tip electrode for Radiofrequency Ablation	Hospital Universitari de Bellvitge	Breast Cancer Female	12/24	12/24
ESCOMA, NCT06955221: Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis	Not yet recruiting	N/A	288	Europe	Ultrasound-guided aspiration and alcohol sclerotherapy	Hospital Universitari de Bellvitge, Carlos III Health Institute	Endometrioma, Ultrasound Therapy; Complications, Quality of Life, Pelvic Pain	04/27	04/28
ADARNAT, NCT04889924: ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer	Recruiting	N/A	1660	Europe, RoW	Axillary Radiotherapy, Lymphadenectomy	Hospital Universitari de Bellvitge	Breast Cancer, Chemotherapy, Sentinel Lymph Node, Axillary Lymph Nodes Dissection, Radiotherapy Side Effect	06/25	12/26
Luna-Tomás, Miguel Ángel
ADARNAT, NCT04889924: ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer	Recruiting	N/A	1660	Europe, RoW	Axillary Radiotherapy, Lymphadenectomy	Hospital Universitari de Bellvitge	Breast Cancer, Chemotherapy, Sentinel Lymph Node, Axillary Lymph Nodes Dissection, Radiotherapy Side Effect	06/25	12/26
Muñiz-Delgado, Andrés
ADARNAT, NCT04889924: ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer	Recruiting	N/A	1660	Europe, RoW	Axillary Radiotherapy, Lymphadenectomy	Hospital Universitari de Bellvitge	Breast Cancer, Chemotherapy, Sentinel Lymph Node, Axillary Lymph Nodes Dissection, Radiotherapy Side Effect	06/25	12/26

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ramos, Manuel
ABIGAIL, NCT04603183 / 2020-001648-24: ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL	Active, not recruiting	2	162	Europe	Abemaciclib, Verzenios, Paclitaxel, Paclitaxel Teva, Letrozole, Fulvestrant	MedSIR, Eli Lilly and Company	Breast Cancer Metastatic	06/24	06/25
PHERGAIN-2, NCT04733118 / 2020-003205-66: Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer	Active, not recruiting	2	393	Europe	Trastuzumab and Pertuzumab (FDC SC) and T-DM1, Trastuzumab emtansine, Phesgo, Kadcyla	MedSIR, Hoffmann-La Roche	Early Breast Cancer	09/25	03/28
Garcia-Tejedor, Amparo
NCT06339658: ICG vs Blue Patent for TAD in cN1 Breast Carcinoma After Neoadjuvant Chemotherapy	Recruiting	N/A	43	Europe	Targeted axillary dissection (TAD) by ICG, Targeted axillary dissection (TAD) by Blue patent	Hospital Universitari de Bellvitge	Breast Cancer, Axillary Metastases	01/26	01/26
NCT03571776: Anti-mullerian Hormone (AMH) After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial	Terminated	N/A	158	Europe	Surgery, Sclerotherapy	Hospital Universitari de Bellvitge	Endometrioma, Fertility Disorders	01/23	01/23
NCT05040685: Axillary Reverse Mapping in Breast Cancer	Completed	N/A	43	Europe	Axillary mapping reverse	Hospital Universitari de Bellvitge	Lymph Node Cancer Metastatic	07/23	07/23
NCT05763641: TAD After Chemotherapy in Locally Advanced Breast Cancer	Recruiting	N/A	162	Europe	Target Axillary Dissection	Hospital Universitari de Bellvitge	Sentinel Lymph Node, Breast Cancer, Locally Advanced	04/25	04/25
NCT05782686: Impact of Systematic Shaving on Margins	Recruiting	N/A	234	Europe	Margin shaving	Hospital Universitari de Bellvitge	Margin, Tumor-Free, Breast Cancer, Surgery	06/24	10/25
NCT04389216: Radiofrequency Ablation (RFA) in Breast Tumors	Recruiting	N/A	30	Europe	Cool-tip electrode for Radiofrequency Ablation	Hospital Universitari de Bellvitge	Breast Cancer Female	12/24	12/24
ESCOMA, NCT06955221: Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis	Not yet recruiting	N/A	288	Europe	Ultrasound-guided aspiration and alcohol sclerotherapy	Hospital Universitari de Bellvitge, Carlos III Health Institute	Endometrioma, Ultrasound Therapy; Complications, Quality of Life, Pelvic Pain	04/27	04/28
ADARNAT, NCT04889924: ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer	Recruiting	N/A	1660	Europe, RoW	Axillary Radiotherapy, Lymphadenectomy	Hospital Universitari de Bellvitge	Breast Cancer, Chemotherapy, Sentinel Lymph Node, Axillary Lymph Nodes Dissection, Radiotherapy Side Effect	06/25	12/26
Luna-Tomás, Miguel Ángel
ADARNAT, NCT04889924: ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer	Recruiting	N/A	1660	Europe, RoW	Axillary Radiotherapy, Lymphadenectomy	Hospital Universitari de Bellvitge	Breast Cancer, Chemotherapy, Sentinel Lymph Node, Axillary Lymph Nodes Dissection, Radiotherapy Side Effect	06/25	12/26
Muñiz-Delgado, Andrés
ADARNAT, NCT04889924: ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer	Recruiting	N/A	1660	Europe, RoW	Axillary Radiotherapy, Lymphadenectomy	Hospital Universitari de Bellvitge	Breast Cancer, Chemotherapy, Sentinel Lymph Node, Axillary Lymph Nodes Dissection, Radiotherapy Side Effect	06/25	12/26